Development and Characterization of 3D Hybrid Spheroids for the Investigation of the Crosstalk Between B-Cell Non-Hodgkin Lymphomas and Mesenchymal Stromal Cells

References

• Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375–2390. doi:10.1182/blood-2016-01-643569
   PubMed Web of Science ®Google Scholar
• Said JW. Aggressive B-cell lymphomas: how many categories do we need? Mod Pathol. 2013;26 Suppl 1(01):S42–S56. doi:10.1038/modpathol.2012.178
   PubMed Web of Science ®Google Scholar
• Campbell J, Seymour JF, Matthews J, et al. The prognostic impact of bone marrow involvement in patients with diffuse large cell lymphoma varies according to the degree of infiltration and presence of discordant marrow involvement. Eur J Haematol. 2006;76(6):473–480. doi:10.1111/j.1600-0609.2006.00644.x
   PubMed Web of Science ®Google Scholar
• Chung R, Lai R, Wei P, et al. Concordant but not discordant bone marrow involvement in diffuse large B-cell lymphoma predicts a poor clinical outcome independent of the International Prognostic Index. Blood. 2007;110(4):1278–1282. doi:10.1182/blood-2007-01-070300
   PubMed Web of Science ®Google Scholar
• Yao Z, Deng L, Xu-Monette ZY, et al. Concordant bone marrow involvement of diffuse large B-cell lymphoma represents a distinct clinical and biological entity in the era of immunotherapy. Leukemia. 2018;32(2):353–363. doi:10.1038/leu.2017.222
   PubMed Web of Science ®Google Scholar
• Crippa S, Santi L, Bosotti R, et al. Bone marrow-derived mesenchymal stromal cells: a novel target to optimize hematopoietic stem cell transplantation protocols in hematological malignancies and rare genetic disorders. J Clin Med. 2019;9(1):2. doi:10.3390/jcm9010002
   PubMed Web of Science ®Google Scholar
• Méndez-Ferrer S, Michurina TV, Ferraro F, et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature. 2012;466(7308):829–834. doi:10.1038/nature09262
   Web of Science ®Google Scholar
• Kidd S, Caldwell L, Dietrich M, et al. Mesenchymal stromal cells alone or expressing interferon-β suppress pancreatic tumors in vivo, an effect countered by anti-inflammatory treatment. Cytotherapy. 2011;13:498.
   Web of Science ®Google Scholar
• He N, Kong Y, Lei X, et al. MSCs inhibit tumor progression and enhance radiosensitivity of breast cancer cells by down-regulating Stat3 signaling pathway. Cell Death Dis. 2018;9(10):1026. doi:10.1038/s41419-018-0949-3
   PubMed Web of Science ®Google Scholar
• De Araújo Farias V, O’Valle F, Lerma BA, et al. Human mesenchymal stem cells enhance the systemic effects of radiotherapy. Oncotarget. 2015;6(31):31164–31180. doi:10.18632/oncotarget.5216
   PubMed Web of Science ®Google Scholar
• Otsu K, Das S, Houser SD, et al. Concentration-dependent inhibition of angiogenesis by mesenchymal stem cells. Blood. 2009;113(18):4197–4205. doi:10.1182/blood-2008-09-176198
   PubMed Web of Science ®Google Scholar
• Dasari VR, Velpula KK, Kaur K, et al. Cord blood stem cell-mediated induction of apoptosis in glioma downregulates X-linked inhibitor of apoptosis protein (XIAP). PLoS One. 2010;5(7):e11813. doi:10.1371/journal.pone.0011813
   PubMed Web of Science ®Google Scholar
• Suzuki K, Sun R, Origuchi M, et al. Mesenchymal stromal cells promote tumor growth through the enhancement of neovascularization. Mol Med. 2011;17(7–8):579–587. doi:10.2119/molmed.2010.00157
   PubMed Web of Science ®Google Scholar
• Karnoub AE, Dash AB, Vo AP, et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature. 2007;449(7162):557–563. doi:10.1038/nature06188
   PubMed Web of Science ®Google Scholar
• Bussard KM, Mutkus L, Stumpf K, et al. Tumor-associated stromal cells as key contributors to the tumor microenvironment. Breast Cancer Res. 2016;18(1):84. doi:10.1186/s13058-016-0740-2
   PubMed Web of Science ®Google Scholar
• Le Naour A, Prat M, Thibault B, et al. Tumor cells educate mesenchymal stromal cells to release chemoprotective and immunomodulatory factors. J Mol Cell Biol. 2020;12(3):202–215. doi:10.1093/jmcb/mjz090
   PubMed Web of Science ®Google Scholar
• Hussain S, Peng B, Cherian M, et al. The roles of stroma-derived chemokine in different stages of cancer metastases. Front Immunol. 2020;11:598532. doi:10.3389/fimmu.2020.598532
   PubMed Web of Science ®Google Scholar
• Hill BS, Sarnella A, D’Avino G, et al. Recruitment of stromal cells into tumour microenvironment promote the metastatic spread of breast cancer. Semin Cancer Biol. 2020;60:202–213. doi:10.1016/j.semcancer.2019.07.028
   PubMed Web of Science ®Google Scholar
• Kumar A, Bhattacharyya J, Jaganathan BG. Adhesion to stromal cells mediates imatinib resistance in chronic myeloid leukemia through ERK and BMP signaling pathways. Sci Rep. 2017;7(1):9535. doi:10.1038/s41598-017-10373-3
   PubMed Web of Science ®Google Scholar
• Mraz M, Zent CS, Church AK, et al. Bone marrow stromal cells protect lymphoma B-cells from rituximab-induced apoptosis and targeting integrin α-4-β-1 (VLA-4) with natalizumab can overcome this resistance. Br J Haematol. 2011;155(1):53–64. doi:10.1111/j.1365-2141.2011.08794.x
   PubMed Web of Science ®Google Scholar
• Janssens R, Struyf S, Proost P. The unique structural and functional features of CXCL12. Cell Mol Immunol. 2018;15(4):299–311. doi:10.1038/cmi.2017.107
   PubMed Web of Science ®Google Scholar
• Lwin T, Crespo LA, Wu A, et al. Lymphoma cell adhesion-induced expression of B cell-activating factor of the TNF family in bone marrow stromal cells protects non-Hodgkin’s B lymphoma cells from apoptosis. Leukemia. 2009;23(1):170–177. doi:10.1038/leu.2008.266
   PubMed Web of Science ®Google Scholar
• Breslin S, O’Driscoll L. Three-dimensional cell culture: the missing link in drug discovery. Drug Discov Today. 2013;18(5–6):240–249. doi:10.1016/j.drudis.2012.10.003
   PubMed Web of Science ®Google Scholar
• Edmondson R, Broglie JJ, Adcock AF, et al. Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors. Assay Drug Dev Technol. 2014;12(4):207–218. doi:10.1089/adt.2014.573
   PubMed Web of Science ®Google Scholar
• Zoetemelk M, Rausch M, Colin DJ, et al. Short-term 3D culture systems of various complexity for treatment optimization of colorectal carcinoma. Sci Rep. 2019;9:7103.
   PubMed Web of Science ®Google Scholar
• Powley IR, Patel M, Miles G, et al. Patient-derived explants (PDEs) as a powerful preclinical platform for anti-cancer drug and biomarker discovery. Br J Cancer. 2020;122(6):735–744. doi:10.1038/s41416-019-0672-6
   PubMed Web of Science ®Google Scholar
• Unger FT, Witte I, David KA. Prediction of individual response to anticancer therapy: historical and future perspectives. Cell Mol Life Sci. 2015;72(4):729–757. doi:10.1007/s00018-014-1772-3
   PubMed Web of Science ®Google Scholar
• Imamura Y, Mukohara T, Shimono Y, et al. Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer. Oncol Rep. 2015;33(4):1837–1843. doi:10.3892/or.2015.3767
   PubMed Web of Science ®Google Scholar
• Tung YC, Hsiao AY, Allen SG, et al. High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array. Analyst. 2011;136(3):473–478. doi:10.1039/C0AN00609B
   PubMed Web of Science ®Google Scholar
• Benelli R, Zocchi MR, Poggi A. Three-Dimensional (3D) culture models in cancer investigation, drug testing and immune response evaluation. Int J Mol Sci. 2020;22(1):150. doi:10.3390/ijms22010150
   PubMed Web of Science ®Google Scholar
• Brüningk SC, Rivens I, Box C, et al. 3D tumour spheroids for the prediction of the effects of radiation and hyperthermia treatments. Sci Rep. 2020;10(1):1653. doi:10.1038/s41598-020-58569-4
   PubMed Web of Science ®Google Scholar
• Luca AC, Mersch S, Deenen R, et al. Impact of the 3D microenvironment on phenotype, gene expression, and EGFR inhibition of colorectal cancer cell lines. PLoS One. 2013;8(3):e59689. doi:10.1371/journal.pone.0059689
   PubMed Web of Science ®Google Scholar
• Goers L, Freemont P, Polizzi KM. Co-culture systems and technologies: taking synthetic biology to the next level. J R Soc Interface. 2014;11(96):20140065. doi:10.1098/rsif.2014.0065
   PubMed Web of Science ®Google Scholar
• Vis MAM, Ito K, Hofmann S. Impact of culture medium on cellular interactions in in vitro co-culture systems. Front Bioeng Biotechnol. 2020;8:911. doi:10.3389/fbioe.2020.00911
   PubMed Web of Science ®Google Scholar
• Mannino RG, Santiago-Miranda AN, Pradhan P, et al. 3D microvascular model recapitulates the diffuse large B-cell lymphoma tumor microenvironment in vitro. Lab Chip. 2017;17(3):407–414. doi:10.1039/C6LC01204C
   PubMed Web of Science ®Google Scholar
• Foxall R, Narang P, Glaysher B, et al. Developing a 3D B cell lymphoma culture system to model antibody therapy. Front Immunol. 2021;11:605231. doi:10.3389/fimmu.2020.605231
   PubMed Web of Science ®Google Scholar
• An JH, Song WJ, Li Q, et al. 3D-culture models as drug-testing platforms in canine lymphoma and their cross talk with lymph node-derived stromal cells. J Vet Sci. 2021;22(3):e25. doi:10.4142/jvs.2021.22.e25
   PubMed Web of Science ®Google Scholar
• Białkowska K, Komorowski P, Bryszewska M, et al. Spheroids as a type of three-dimensional cell cultures-examples of methods of preparation and the most important application. Int J Mol Sci. 2020;21(17):6225. doi:10.3390/ijms21176225
   PubMed Web of Science ®Google Scholar
• LaBarbera DV, Reid BG, Yoo BH. The multicellular tumor spheroid model for high throughput cancer drug discovery. Expert Opin Drug Discov. 2012;7(9):819–830. doi:10.1517/17460441.2012.708334
   PubMed Web of Science ®Google Scholar
• Monjaret F, Fernandes M, Duchemin-Pelletier E, et al. Fully automated one-step production of functional 3D tumor spheroids for high-content screening. J Lab Autom. 2016;21(2):268–280. doi:10.1177/2211068215607058
   PubMedGoogle Scholar
• Caliari SR, Burdick JA. A practical guide to hydrogels for cell culture. Nat Methods. 2016;13(5):405–414. doi:10.1038/nmeth.3839
   PubMed Web of Science ®Google Scholar
• Lee JM, Park DY, Yang L, et al. Generation of uniform-sized multicellular tumor spheroids using hydrogel microwells for advanced drug screening. Sci Rep. 2018;8(1):17145. doi:10.1038/s41598-018-35216-7
   PubMed Web of Science ®Google Scholar
• Lutolf MP, Hubbell JA. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol. 2005;23(1):47–55. doi:10.1038/nbt1055
   PubMed Web of Science ®Google Scholar
• Tibbitt MW, Anseth KS. Hydrogels as extracellular matrix mimics for 3D cell culture. Biotechnol Bioeng. 2009;103(4):655–663. doi:10.1002/bit.22361
   PubMed Web of Science ®Google Scholar
• Determining fluorescence intensity and signal. University of Maryland, Baltimore County. Available from: https://kpif.umbc.edu/image-processing-resources/imagej-fiji/determining-fluorescence-intensity-and-positive-signal/. Accessed December 21, 2021.
   Google Scholar
• Bio-Rad colorimetric and fluorometric calculator. Available from: https://www.bio-rad-antibodies.com/colorimetric-calculator-fluorometric-alamarblue.html. Accessed December 21, 2021.
   Google Scholar
• Eilenberger C, Kratz SRA, Rothbauer M, et al. Optimized alamarBlue assay protocol for drug dose-response determination of 3D tumor spheroids. MethodsX. 2018;5:781–787. doi:10.1016/j.mex.2018.07.011
   PubMed Web of Science ®Google Scholar
• Meads MB, Hazlehurst LA, Dalton WS. The bone marrow microenvironment as a tumor sanctuary and contributor to drug resistance. Clin Cancer Res. 2008;14(9):2519–2526. doi:10.1158/1078-0432.CCR-07-2223
   PubMed Web of Science ®Google Scholar
• Lee MW, Ryu S, Kim DS, et al. Mesenchymal stem cells in suppression or progression of hematologic malignancy: current status and challenges. Leukemia. 2019;33(3):597–611. doi:10.1038/s41375-018-0373-9
   PubMed Web of Science ®Google Scholar
• Galland S, Stamenkovic I. Mesenchymal stromal cells in cancer: a review of their immunomodulatory functions and dual effects on tumor progression. J Pathol. 2020;250(5):555–572. doi:10.1002/path.5357
   PubMed Web of Science ®Google Scholar
• Liang W, Chen X, Zhang S, et al. Mesenchymal stem cells as a double-edged sword in tumor growth: focusing on MSC-derived cytokines. Cell Mol Biol Lett. 2021;26(1):3. doi:10.1186/s11658-020-00246-5
   PubMed Web of Science ®Google Scholar
• Wu YL, Li HY, Zhao XP, et al. Mesenchymal stem cell‐derived CCN2 promotes the proliferation, migration and invasion of human tongue squamous cell carcinoma cells. Cancer Sci. 2017;108(5):897–909. doi:10.1111/cas.13202
   PubMed Web of Science ®Google Scholar
• Yulyana Y, Ho IA, Sia KC, et al. Paracrine factors of human fetal MSCs inhibit liver cancer growth through reduced activation of IGF-1R/PI3K/Akt signaling. Mol Ther. 2015;23(4):746–756. doi:10.1038/mt.2015.13
   PubMed Web of Science ®Google Scholar
• Klopp AH, Gupta A, Spaeth E, et al. Concise review: dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth? Stem Cells. 2011;29(1):11–19. doi:10.1002/stem.559
   PubMed Web of Science ®Google Scholar
• Li L, Tian H, Yue W, et al. Human mesenchymal stem cells play a dual role on tumor cell growth in vitro and in vivo. J Cell Physiol. 2011;226(7):1860–1867. doi:10.1002/jcp.22511
   PubMed Web of Science ®Google Scholar
• Wang Q, Li T, Wu W, et al. Interplay between mesenchymal stem cell and tumor and potential application. Hum Cell. 2020;33(3):444–458. doi:10.1007/s13577-020-00369-z
   PubMed Web of Science ®Google Scholar
• Duś-Szachniewicz K, Drobczyński S, Woźniak M, et al. Differentiation of single lymphoma primary cells and normal B-cells based on their adhesion to mesenchymal stromal cells in optical tweezers. Sci Rep. 2019;9(1):9885. doi:10.1038/s41598-019-46086-y
   PubMed Web of Science ®Google Scholar
• Duś-Szachniewicz K, Drobczyński S, Ziółkowski P, et al. Physiological Hypoxia (Physioxia) impairs the early adhesion of single lymphoma cell to marrow stromal cell and extracellular matrix. Optical Tweezers Study. Int J Mol Sci. 2018;19(7):1880. doi:10.3390/ijms19071880
   PubMed Web of Science ®Google Scholar
• Gava F, Faria C, Gravelle P, et al. 3D model characterization by 2D and 3D imaging in t(14;18)-positive B-NHL: perspectives for in vitro drug screens in follicular lymphoma. Cancers. 2021;13(7):1490. doi:10.3390/cancers13071490
   PubMed Web of Science ®Google Scholar
• Barbaglio F, Belloni D, Scarfò L, et al. Three-dimensional co-culture model of chronic lymphocytic leukemia bone marrow microenvironment predicts patient-specific response to mobilizing agents. Haematologica. 2021;106(9):2334–2344. doi:10.3324/haematol.2020.248112
   PubMed Web of Science ®Google Scholar
• Adamo A, Delfino P, Gatti A, et al. HS-5 and HS-27A stromal cell lines to study bone marrow mesenchymal stromal cell-mediated support to cancer development. Front Cell Dev Biol. 2020;8:584232. doi:10.3389/fcell.2020.584232
   PubMed Web of Science ®Google Scholar
• Belloni D, Heltai S, Ponzoni M, et al. Modeling multiple myeloma-bone marrow interactions and response to drugs in a 3D sur rogate microenvironment. Haematologica. 2018;103(4):707–716. doi:10.3324/haematol.2017.167486
   PubMed Web of Science ®Google Scholar
• Maritan SM, Lian EY, Mulligan LM. An efficient and flexible cell aggregation method for 3d spheroid production. J Vis Exp. 2017;121:55544.
   Google Scholar
• McHowat J, Swift LM, Arutunyan A, et al. Clinical concentrations of doxorubicin inhibit activity of myocardial membrane-associated, calcium-independent phospholipase A(2). Cancer Res. 2001;61(10):4024–4029.
   PubMed Web of Science ®Google Scholar
• Xu P, Zuo H, Chen B, et al. Doxorubicin-loaded platelets as a smart drug delivery system: an improved therapy for lymphoma. Sci Rep. 2017;7(1):42632. Erratum in: Sci Rep. 2017;7:44974. doi:10.1038/srep42632
   PubMed Web of Science ®Google Scholar
• Ma J, Lu P, Guo A. Characterization of ibrutinib-sensitive and -resistant mantle lymphoma cells. Br J Haematol. 2014;166(6):849–861. doi:10.1111/bjh.12974
   PubMed Web of Science ®Google Scholar
• Wu W, Wang W, Franzen CA. at al. Inhibition of B-cell receptor signaling disrupts cell adhesion in mantle cell lymphoma via RAC2. Blood Adv. 2021;5(1):185–197. doi:10.1182/bloodadvances.2020001665
   PubMed Web of Science ®Google Scholar
• Mai Y, Yu JJ, Bartholdy B, et al. An oxidative stress-based mechanism of doxorubicin cytotoxicity suggests new therapeutic strategies in ABC-DLBCL. Blood. 2016;128(24):2797–2807. doi:10.1182/blood-2016-03-705814
   PubMed Web of Science ®Google Scholar
• Lamaison C, Latour S, Hélaine N, et al. A novel 3D culture model recapitulates primary FL B-cell features and promotes their survival. Blood Adv. 2021;5(23):5372–5386. doi:10.1182/bloodadvances.2020003949
   PubMed Web of Science ®Google Scholar
• Hou K, Yu Z, Jia Y, et al. Efficacy and safety of ibrutinib in diffuse large B-cell lymphoma: a single-arm meta-analysis. Crit Rev Oncol Hematol. 2020;152:103010. doi:10.1016/j.critrevonc.2020.103010
   PubMed Web of Science ®Google Scholar
• Bray LJ, Binner M, Körner Y, et al. A three-dimensional ex vivo tri-culture model mimics cell-cell interactions between acute myeloid leukemia and the vascular niche. Haematologica. 2017;102:1215–1226. doi:10.3324/haematol.2016.157883
   PubMed Web of Science ®Google Scholar
• Khawar IA, Park JK, Jung ES, et al. Three dimensional mixed-cell spheroids mimic stroma-mediated chemoresistance and invasive migration in hepatocellular carcinoma. Neoplasia. 2018;20(8):800–812. doi:10.1016/j.neo.2018.05.008
   PubMed Web of Science ®Google Scholar
• Yip D, Cho CH. A multicellular 3D heterospheroid model of liver tumor and stromal cells in collagen gel for anti-cancer drug testing. Biochem Biophys Res Commun. 2013;433(3):327–332. doi:10.1016/j.bbrc.2013.03.008
   PubMed Web of Science ®Google Scholar